Future Market Insights.png
Global Antiepileptic Drug Market to Reach USD 28.72 Billion by 2034 Amid Growing Demand for Innovative Epilepsy Therapies | Future Market Insights, Inc.
December 09, 2024 10:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Future Market Insight's latest analysis highlights significant growth potential in the global antiepileptic drug market, forecasting an increase from...
Global Neurologic Disorders Therapeutics Market
Neurologic Disorders Therapeutics Strategic Business Report 2024: Global Market to Reach $149.7 Billion by 2030, Driven by Development of Regenerative Medicine and Stem Cell Therapies
October 22, 2024 09:43 ET | Research and Markets
Dublin, Oct. 22, 2024 (GLOBE NEWSWIRE) -- The "Neurologic Disorders Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Global Epilepsy Drugs Market
Epilepsy Drugs Market Report and Global Forecast 2024-2030, Featuring Eisai, UCB, H. Lundbeck, GW Pharmaceuticals, Abbott, Alkem Laboratories, Bausch Health Companies, GSK, Novartis and Pfizer
May 06, 2024 04:04 ET | Research and Markets
Dublin, May 06, 2024 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Top Companies Analysis" report has...
22157.jpg
Migraine in America: Key Insights into Treatment Awareness & Satisfaction - Exploring HCP Engagement and Migraine Treatment Experiences Among Patients
April 02, 2024 07:18 ET | Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "Migraine in America 2023: Key Insights into Treatment Awareness & Satisfaction" report has been added to ResearchAndMarkets.com's offering. In...
Antiepileptic Drugs (AED) Market Globenewswire
Antiepileptic Drugs Market Size to Surpass USD 22.37 billion by 2030, exhibiting a CAGR of 4.4%
November 20, 2023 06:16 ET | Fortune Business Insights
Pune, India, Nov. 20, 2023 (GLOBE NEWSWIRE) -- The antiepileptic drugs market size is anticipated to surge from USD 16.50 billion in 2023 to USD 22.37 billion by 2030, exhibiting a CAGR of 4.4% over...
22157.jpg
Second Generation Anti-Epileptic Drugs (AEDs) Dominate the Market in 2022, While Third Generation AEDs Projected to Exhibit the Fastest Growth
November 06, 2023 06:58 ET | Research and Markets
Dublin, Nov. 06, 2023 (GLOBE NEWSWIRE) -- The "Global Anti-Epileptic Drugs Market: Analysis By Drug Generation, By Distribution Channel, By Region Size and Trends with Impact of COVID-19 and...
Global Phenobarbital Market
Proven Track Record in Epilepsy Treatment Propels Global Phenobarbital Market; Anticipated to Reach $2.23 Billion by 2030
September 08, 2023 08:28 ET | Research and Markets
Dublin, Sept. 08, 2023 (GLOBE NEWSWIRE) -- The "Phenobarbital Market, By Indication, By Dosage Form, By Distribution Channel, and By Geography- Size, Share, Outlook, and Opportunity Analysis, 2023 -...
NeuroSigma.png
NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®
February 22, 2022 11:00 ET | NeuroSigma, Inc.
LOS ANGELES, Feb. 22, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for...
22157.jpg
Global Epilepsy Drugs Market (2020 to 2027) - Featuring UCB, Eisai, H. Lundbeck and GW Pharmaceuticals
September 15, 2021 04:28 ET | Research and Markets
Dublin, Sept. 15, 2021 (GLOBE NEWSWIRE) -- The "Epilepsy Drugs Market, Global Forecast, Impact of COVID-19, Industry Trends, by Drugs Category, Growth, Opportunity Company Analysis" report has been...
FBI LOGO TM.png
Antiepileptic Drugs Market to Reach USD 20.33 Billion by 2026; Rising Production of Innovative Drugs to Boost Growth: says Fortune Business Insights™
April 08, 2020 12:20 ET | Fortune Business Insights
Pune, April 08, 2020 (GLOBE NEWSWIRE) -- The global antiepileptic drugs (AED) market is set to gain traction from the ever-increasing initiatives by manufacturers for producing novel and generic...